<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v6i1.2877</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Xiaohong Cheng’s Clinical Experience in Treating Membranous Nephropathy</title><url>https://artdesignp.com/journal/JCNR/6/1/10.26689/jcnr.v6i1.2877</url><author>JiangGuanhua,WangYu,ChengXiaohong</author><pub-date pub-type="publication-year"><year>2022</year></pub-date><volume>6</volume><issue>1</issue><history><date date-type="pub"><published-time>2022-01-19</published-time></date></history><abstract>Membranous nephropathy is the most common pathological type of nephrotic syndrome in adult patients. In recent years, the incidence of membranous nephropathy has been increasing year by year. The pathogenesis of membranous nephropathy has not been completely clear yet. Professor Xiaohong Cheng has accumulated a lot of clinical experience in the treatment of membranous nephropathy, and believes that the main pathogenesis of membranous nephropathy is “spleen and kidney deficiency, kidney blockage.” The main treatment method is “invigorating spleen and kidney, promoting blood circulation and clearing collaterals,” which has achieved remarkable clinical efficacy.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Qi L, Ran R, Li Z, et al., 2021, Yuyong Zhao’s Experience in the Treatment of Membranous Nephropathy. Jiangsu TCM, 53(08): 20-22.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Feng D, 2018, Professor Hongsheng Lv differentiated Treatment of Idiopathic Membranous Nephropathy Syndrome. Henan University of Chinese Medicine.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Le Y, Cheng X, 2018, Experience of Treating Idiopathic Membranous Nephropathy with Turmeric and Polygonum Cuspidatum. Yunnan Journal of TCM, 39(10): 6-8.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Zheng R, 2016, Study on Pharmacological Action and Clinical Application of Astragalus Membranaceus. Chinese Practical Medicine, 11(32): 190-191.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Liu J, Lin Y, Zhang X, et al., 2016, Advances in Processing of Atractylodes Macrocephala. Shandong Journal of TCM, 35(11): 1005-1008.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Cui H, Wang R, Guo W, et al., 2019, Advances in Chemical Constituents, Pharmacological Action and Clinical Application of Poria cocos. Northwest Pharmaceutical Journal, 34(05): 694-700.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Ying Z, Lu H, 2020, Research Progress on Chemical Constituents and Pharmacological Action of Psoraleae. Electronic Journal of Clinical Medicine Literature, 7(30): 195.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Dan X, Yan D, Wang Y, et al., 2009, Advances in Pharmacology and Toxicology of Psoraleae and its Related Chemical Constituents. Journal of Liaoning University of TCM, 11(07): 70-72.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Liu L, Yang H, 2011, Professor Hongtao Yang’s Experience in Treating Nephrotic Syndrome with Chinese Medicine to Alleviate Hormone Side Effects. Jilin TCM, 31(10): 941-942.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Jin M, Zheng H, 2007, Study on the Effects of Chinese Medicine on Glucocorticoid. Journal of Liaoning University of TCM, (02): 23-24.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Si L, Qin H, Deng L, et al., 2021, Advances in Pharmacological Action and Mechanism of Polydatin. Chinese Journal of Experimental Formulae, 27(22): 241-250.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Wei L, Gu X, Wu X, et al., 2021, Research Progress on Pharmacological Action of Curcumin. West China Journal of Pharmacy, 36(03): 336-340.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
